The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Biogen Inc

Nasdaq: BIIB
Last

(U.S.) $287.78

Today's change+5.33 +1.89%
Updated July 22 4:00 PM EDT. Delayed by at least 15 minutes.
 

Biogen Inc

Nasdaq: BIIB
Last

(U.S.) $287.78

Today's change+5.33 +1.89%
Updated July 22 4:00 PM EDT. Delayed by at least 15 minutes.

Biogen Inc Hits New 20-day High

Biogen Inc closed up sharply Friday, rallying (U.S.)$5.33 or 1.89% to (U.S.)$287.78 and setting a new 20-day high. Over the last five days, shares have gained 10.56%, but are down 6.06% for the last year to date. Shares have underperformed the S&P 500 by 29.42% during the last year.

Key company metrics

  • Open(U.S.) $282.09
  • Previous close(U.S.) $282.45
  • High(U.S.) $290.92
  • Low(U.S.) $281.38
  • Bid / Ask(U.S.) $288.25 / (U.S.) $297.00
  • YTD % change-6.06%
  • Volume3,394,578
  • Average volume (10-day)2,109,461
  • Average volume (1-month)2,059,511
  • Average volume (3-month)1,859,788
  • 52-week range(U.S.) $223.02 to (U.S.) $401.11
  • Beta0.92
  • Trailing P/E16.80×
  • P/E 1 year forward14.53×
  • Forward PEG1.59×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $17.13
Updated July 22 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.24%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue2,7272,8392,7782,592
Total other revenue--------
Total revenue2,7272,8392,7782,592
Gross profit2,4142,5082,4682,306
Total cost of revenue313332310286
Total operating expense1,3481,6711,4061,359
Selling / general / administrative497583478492
Research & development437542520491
Depreciation / amortization89979892
Interest expense (income), net operating--------
Unusual expense (income)121180-2
Other operating expenses, total--------
Operating income1,3781,1681,3721,233
Interest income (expense), net non-operating-63-67-16-6
Gain (loss) on sale of assets--------
Other--------
Income before tax1,3261,0861,3561,222
Income after tax9698291,026930
Income tax, total356257330293
Net income971832966927
Total adjustments to net income--------
Net income before extra. items971832966927
Minority interest23-542
Equity in affiliates00-7-5
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items971832966927
Inc. avail. to common incl. extra. items971832966927
Diluted net income971832966927
Dilution adjustment--------
Diluted weighted average shares219221233236
Diluted EPS excluding extraordinary itemsvalue per share4.433.774.153.93
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share4.474.174.153.93